US-Funded $1.6M Trial of Hepatitis B Birth Dose in Guinea-Bissau Draws Ethics Backlash

Overview: The US will fund a $1.6 million, five-year randomized trial in Guinea-Bissau testing whether newborns who do or do not receive a hepatitis B vaccine at birth differ in early-life outcomes. Experts cal...



























